Tests an online plant-based diet program for adults with diabetes or excess weight
Tests a plant-based diet education program in adults with diabetes or overweight.
Plain-language title generated from the registry record
Registry title: Plant-Based Online Weight Loss Through Education and Resources Program and Study
Key facts
- Where
- Washington D.C., United StatesSee the site
Where in United States
- Physicians Committee for Responsible MedicineWashington D.C., United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Physicians Committee for Responsible Medicine
- Trial code
- NCT07095543
- Record updated
- 17 September 2026
- Original description
This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Participants will meet with a physician and a registered dietitian once a week to learn about a plant-based diet and receive support and practical help in making the dietary changes. Body composition, blood sugar control, cholesterol levels, and food costs will be measured at the start and end of the study.Read full original descriptionShow less
Feasibility, Implementation, and Efficacy of a Plant-based Online Weight Loss Through Education and Resources Program and Study (POWER Study)
This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Participants will meet with a physician and a registered dietitian once a week to learn about a plant-based diet and receive support and practical help in making the dietary changes. Body composition, blood sugar control, cholesterol levels, and food costs will be measured at the start and end of the study.
Inclusion: U.S. men and women meeting the age of majority, defined as follows:; Age 19 or older in Nebraska and Alabama. Age 21 or older in Puerto Rico. Age 18 or older in all other states; Able and willing to travel to Washington DC for a dual-energy х-rау absorptiometry (DXA) scans before and after the program; Able and willing to complete laboratory assessments at a local LabCorp facility before and after the program; Able and willing to participate in all components of the study; BMI of 25 or more (23 or more in persons of Asian origin); Access to the internet; English fluency.
Exclusion: Use of recreational drugs in the past 6 months; Inability to maintain medication regimen as prescribed by personal healthcare provider; Unstable medical or psychiatric illness; Current diagnosis of eating disorder; Current or expected use of any weight loss medication during the study period, including but not limited to, glucagon-like peptide-1 (GLP-1) receptor agonists and combination GLP-1 receptor/glucose-dependent insulinotropic polypeptide (GIP) agonists; Use of any weight loss medication within the 12 months preceding the study period, including but not limited to, glucagon-like peptide-1 (GLP-1) receptor agonists and combination GLP-1 receptor/glucose-dependent insulinotropic polypeptide (GIP) agonists; Pregnancy or intention to become pregnant during the study period, as verified by self-report; Body weight greater than 182 kg; Intention to follow another weight loss method during the study period.